BLIS M18 is the second oral-health probiotic strain from Blis Technologies and its North American distributor Stratum Nutrition.
Photo © iStockphoto.com/Kurhan
BLIS M18, the second oral-health probiotic strain from Blis Technologies (Dunedin, NZ) and its North American distributor Stratum Nutrition (Carthage, MO), has received a “Letter of No Objection” from the U.S. FDA in responses to a filing for Generally Recognized as Safe (GRAS) status.
Blis Technologies previously received a Letter of No Objection GRAS response for its first, well-known oral-health probiotic strain BLIS K12. Said the companies in a press release: “GRAS status adds a new level of credibility for BLIS M18 and has the potential to open up opportunities with larger consumer food and beverage companies in the U.S., but also is recognized as a relevant and credible safety assessment by other countries and multinational companies.”
Women in Nutraceuticals to hold first annual WIN Awards at SupplySide West 2024
October 16th 2024According to the organization’s press release, the awards program is designed to “celebrate the remarkable contributions and achievements of those who champion gender equity, drive research innovations, excel in mentorship within the nutraceutical sector, and significantly contribute to WIN’s programs.”
Kyowa Hakko USA to share new research on its Cognizin citicoline ingredient at SupplySide West 2024
Published: October 15th 2024 | Updated: October 15th 2024According to the company, the new research demonstrates the ingredient’s neuroprotective qualities and potential to enhance cognitive function, and support healthy brain aging.